

NCT01891513 comparison:

Summary:
CHIA has 26 criteria while your personal folder has 26 criteria
Total found criteria: 26/26
Total not Found: 0/26
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Age 65 years and older                             │ Age 65 years and older                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hypertension - untreated (Systolic Blood Pressure  │ Hypertension - untreated (Systolic Blood Pressure  │
│ (SBP) ≥ 140 mm Hg or Diastolic Blood Pressure      │ (SBP) ≥ 140 mm Hg or Diastolic Blood Pressure      │
│ (DBP) ≥ 90 mm Hg) or treated                       │ (DBP) ≥ 90 mm Hg) or treated                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Physical limitations evidenced by either           │ Physical limitations evidenced by either           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Score ≤ 10 on the Short Physical Performance       │ Score ≤ 10 on the Short Physical Performance       │
│ Battery OR Walking speed < 1.2 m/sec during 400 m  │ Battery OR Walking speed \< 1.2 m/sec during 400 m │
│ usual-paced test                                   │ usual-paced test                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Sedentary lifestyle, defined as <150 min/wk of     │ Sedentary lifestyle, defined as \<150 min/wk of    │
│ moderate physical activity as assessed by CHAMPS   │ moderate physical activity as assessed by CHAMPS   │
│ questionnaire                                      │ questionnaire                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Willingness to participate in all study procedures │ Willingness to participate in all study procedures │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Failure to provide informed consent                │ Failure to provide informed consent                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Inability to complete 400 m walk within 15 minutes │ Inability to complete 400 m walk within 15 minutes │
│ without sitting or interpersonal assistance, as an │ without sitting or interpersonal assistance, as an │
│ indicator of disablement and likely inability to   │ indicator of disablement and likely inability to   │
│ fully engage in the exercise intervention          │ fully engage in the exercise intervention          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Primary indication for ACE inhibitor use, i.e.     │ Primary indication for ACE inhibitor use, i.e.     │
│ Congestive Heart Failure, CAD, diabetes            │ Congestive Heart Failure, CAD, diabetes            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known hypersensitivity to ACE inhibitors           │ Known hypersensitivity to ACE inhibitors           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Resistant hypertension, defined as BP > 140/90,    │ Resistant hypertension, defined as BP \> 140/90,   │
│ despite the use of three or more anti-hypertensive │ despite the use of three or more anti-hypertensive │
│ drugs                                              │ drugs                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Office or average home SBP > 180 mm Hg or DBP >    │ Office or average home SBP \> 180 mm Hg or DBP \>  │
│ 110 mm Hg (Average home BP in any seven day period │ 110 mm Hg (Average home BP in any seven day period │
│ during trial)                                      │ during trial)                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Primary renal disease                              │ Primary renal disease                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Serum creatinine >2.5 mg/dL in men, or >2.0 mg/dL  │ Serum creatinine \>2.5 mg/dL in men, or \>2.0      │
│ in women                                           │ mg/dL in women                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Serum potassium >5.0 molar equivalent/L            │ Serum potassium \>5.0 molar equivalent/L           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Urinary protein > 1 on dipstick                    │ Urinary protein \> 1 on dipstick                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Abnormal liver enzymes (Aspartate transaminase     │ Abnormal liver enzymes (Aspartate transaminase     │
│ (AST), Alanine transaminase (ALT), or alkaline     │ (AST), Alanine transaminase (ALT), or alkaline     │
│ phosphatase > 2.5 times the upper limit of normal) │ phosphatase \> 2.5 times the upper limit of        │
│                                                    │ normal)                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe cardiac disease, including New York Heart   │ Severe cardiac disease, including New York Heart   │
│ Association Class III or IV congestive heart       │ Association Class III or IV congestive heart       │
│ failure, clinically significant aortic stenosis,   │ failure, clinically significant aortic stenosis,   │
│ history of cardiac arrest, use of a cardiac        │ history of cardiac arrest, use of a cardiac        │
│ defibrillator, or uncontrolled angina              │ defibrillator, or uncontrolled angina              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acute myocardial infarction identified by ECG      │ Acute myocardial infarction identified by ECG      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Lives in a nursing home (persons living in         │ Lives in a nursing home (persons living in         │
│ assisted or independent housing will not be        │ assisted or independent housing will not be        │
│ excluded)                                          │ excluded)                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Significant cognitive impairment, defined as a     │ Significant cognitive impairment, defined as a     │
│ known diagnosis of dementia or a Mini-Mental State │ known diagnosis of dementia or a Mini-Mental State │
│ Examination exam score < 24                        │ Examination exam score \< 24                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Unable to communicate because of severe hearing    │ Unable to communicate because of severe hearing    │
│ loss or speech disorder                            │ loss or speech disorder                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Severe visual impairment, which would preclude     │ Severe visual impairment, which would preclude     │
│ completion of the assessments and/or intervention  │ completion of the assessments and/or intervention  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Other significant co-morbid disease that would     │ Other significant co-morbid disease that would     │
│ prevent participation in exercise                  │ prevent participation in exercise                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Planning to move out of the area during the study  │ Planning to move out of the area during the study  │
│ time frame                                         │ time frame                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Simultaneous participation in another intervention │ Simultaneous participation in another intervention │
│ trial                                              │ trial                                              │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 65 Years │
╘═══════════════════════════════════╛